Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.46 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10072289 | 0.92 | LMNA (0.52) | TSHRHIF1ASMN1; SMN2LMNAKDM4E | |
| SCHEMBL14904491 | 0.88 | PLA2G4B (0.53) | MAPK1TSHRHIF1AKDM4E | |
| SCHEMBL10072400 | 0.88 | TSHR (0.61) | MAPK1TSHRHIF1ASMN1; SMN2LMNA | |
| SCHEMBL14904485 | 0.86 | KCNA3 (0.50) | SMN1; SMN2LMNAKDM4EL3MBTL1CYP2D6 | |
| SCHEMBL2721719 | 0.84 | LMNA (0.42) | MAPK1TSHRHIF1ALMNAKDM4E | |
| SCHEMBL11400908 | 0.82 | LMNA (0.61) | TSHRHIF1ASMN1; SMN2LMNAKDM4E | |
| SCHEMBL12222360 | 0.82 | LMNA (0.53) | MAPK1TSHRHIF1ASMN1; SMN2LMNA | |
| SCHEMBL10713338 | 0.82 | RECQL (0.53) | TSHRHIF1ASMN1; SMN2LMNAKDM4E | |
| SCHEMBL10711050 | 0.82 | RECQL (0.53) | TSHRHIF1ASMN1; SMN2LMNAKDM4E | |
| SCHEMBL10710354 | 0.81 | RECQL (0.57) | TSHRHIF1ASMN1; SMN2LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023209463-A1 | DENTAL COMPOSITION CONTAINING A RESORCINOL OR CATECHOL MOIETY CONTAINING COMPONENT AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-02 | — | — | WO | disclosed |
| EP-2670375-B1 | DENTAL COMPOSITION, METHOD OF PRODUCING AND USE THEREOF | 3M INNOVATIVE PROPERTIES CO (US) | 2019-05-01 | — | — | EP | disclosed |
| US-10022306-B2 | Dental compositions comprising a fatty mono(meth)acrylate | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-17 | — | — | US | disclosed |
| US-10022306-B2 | Dental compositions comprising a fatty mono(meth)acrylate | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-17 | — | — | US | disclosed |
| US-20160361238-A1 | DENTAL COMPOSITIONS COMPRISING A FATTY MONO(METH)ACRYLATE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-12-15 | — | — | US | disclosed |
| US-20160361238-A1 | DENTAL COMPOSITIONS COMPRISING A FATTY MONO(METH)ACRYLATE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-12-15 | — | — | US | disclosed |
| US-9433563-B2 | Dental compositions comprising a fatty mono(meth)acrylate | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-09-06 | — | — | US | disclosed |
| US-9433563-B2 | Dental compositions comprising a fatty mono(meth)acrylate | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-09-06 | — | — | US | disclosed |
| US-9295617-B2 | Dental composition, method of producing and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-03-29 | — | — | US | disclosed |
| US-9295617-B2 | Dental composition, method of producing and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-03-29 | — | — | US | disclosed |
| US-8710113-B2 | Dental composition, kit of parts and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-04-29 | — | — | US | disclosed |
| US-8710113-B2 | Dental composition, kit of parts and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-04-29 | — | — | US | disclosed |
| US-20130303655-A1 | DENTAL COMPOSITION, METHOD OF PRODUCING AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-11-14 | — | — | US | disclosed |
| US-20130303655-A1 | DENTAL COMPOSITION, METHOD OF PRODUCING AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-11-14 | — | — | US | disclosed |
| US-20130109777-A1 | DENTAL COMPOSITION, KIT OF PARTS AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-05-02 | — | — | US | disclosed |
| US-20130109777-A1 | DENTAL COMPOSITION, KIT OF PARTS AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-05-02 | — | — | US | disclosed |
| EP-2481390-A1 | Dental composition, method of producing and use thereof | 3M Innovative Properties Company (US) | 2012-08-01 | — | — | EP | disclosed |
| WO-2012003136-A1 | DENTAL COMPOSITION, KIT OF PARTS AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-01-05 | — | — | WO | disclosed |
| EP-2401998-A1 | Dental composition, kit of parts and use thereof | 3M Innovative Properties Company (US) | 2012-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303655-A1 | DENTAL COMPOSITION, METHOD OF PRODUCING AND USE THEREOF | PAM, PTMS, ACR | MAPK1 4208/4885TSHR 3551/4885HIF1A 1518/4885 |
| US-20160361238-A1 | DENTAL COMPOSITIONS COMPRISING A FATTY MONO(METH)ACRYLATE | MMAB, ELOVL5, ELOVL1 | MAPK1 3767/4885TSHR 2838/4885HIF1A 1972/4885 |
| US-10022306-B2 | Dental compositions comprising a fatty mono(meth)acrylate | MMAB, ELOVL5, ELOVL1 | MAPK1 3767/4885TSHR 2838/4885HIF1A 1972/4885 |
| US-20130109777-A1 | DENTAL COMPOSITION, KIT OF PARTS AND USE THEREOF | KIT, KDM5C, PHAX | MAPK1 2853/4885TSHR 4041/4885HIF1A 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.